CDC27 and central nervous system cancer: Results from pathological studies unveiled a series of mutations in ANAPC3/Apc3, ANAPC6/Apc6, and ANAPC8/Apc8 in breast cancer, colon cancer, glioma, hepatocarcinoma, melanoma, neuroblastoma, choriocarcinoma tissues [157].